Correlation Between Singular Genomics and Medirom Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Singular Genomics and Medirom Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Singular Genomics and Medirom Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Singular Genomics Systems and Medirom Healthcare Technologies, you can compare the effects of market volatilities on Singular Genomics and Medirom Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Singular Genomics with a short position of Medirom Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Singular Genomics and Medirom Healthcare.

Diversification Opportunities for Singular Genomics and Medirom Healthcare

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Singular and Medirom is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Singular Genomics Systems and Medirom Healthcare Technologie in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medirom Healthcare and Singular Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Singular Genomics Systems are associated (or correlated) with Medirom Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medirom Healthcare has no effect on the direction of Singular Genomics i.e., Singular Genomics and Medirom Healthcare go up and down completely randomly.

Pair Corralation between Singular Genomics and Medirom Healthcare

Given the investment horizon of 90 days Singular Genomics Systems is expected to generate 0.98 times more return on investment than Medirom Healthcare. However, Singular Genomics Systems is 1.02 times less risky than Medirom Healthcare. It trades about 0.06 of its potential returns per unit of risk. Medirom Healthcare Technologies is currently generating about 0.02 per unit of risk. If you would invest  1,167  in Singular Genomics Systems on August 24, 2024 and sell it today you would earn a total of  1,023  from holding Singular Genomics Systems or generate 87.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Singular Genomics Systems  vs.  Medirom Healthcare Technologie

 Performance 
       Timeline  
Singular Genomics Systems 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Singular Genomics Systems are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain forward indicators, Singular Genomics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Medirom Healthcare 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medirom Healthcare Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Singular Genomics and Medirom Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Singular Genomics and Medirom Healthcare

The main advantage of trading using opposite Singular Genomics and Medirom Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Singular Genomics position performs unexpectedly, Medirom Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medirom Healthcare will offset losses from the drop in Medirom Healthcare's long position.
The idea behind Singular Genomics Systems and Medirom Healthcare Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets